The European regulator approves Sandoz' (NYSE: NVS ) Simbrinza eye drops suspension ( brinzolamide 10 mg/ml and brimonidine tartrate 2mg/ml) to decrease intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for which monotherapy provides insufficient IOP ...
inadequately to or who are intolerant to previous therapy with one or more disease-modifying antirheumatic drugs or tumor necrosis factor antagonists. A final decision by the European Commission usually takes ~3 months. Post your comment!
BRUSSELS, July 28 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
ZURICH, July 28 (Reuters) - Swiss pharmaceutical group Novartis said the European Commission has approved its eyecare unit Alcon's Simbrinza treatment for glaucoma, a chronic, sight-threatening eye disease.
Switzerland GmbH. Once approved, Janssen will market it exclusively in EMEA (Europe, Middle East, Africa) and co-promote it in the U.S. A final decision from the European Commission usually takes ~3 months. Post your comment!
BRUSSELS, July 25 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
Committee also supports the use of Zydelig as a monotherapy for the treatment of FL in patients refractory to two prior lines of treatment. A final decision from the European Commission typically takes ~3 months. Post your comment!
COPENHAGEN, July 25 (Reuters) - Novo Nordisk, the world's largest insulin maker, said on Friday it expected European Commission marketing authorisation for its new two-in-one insulin drug within three months after an EU medicines agency recommended the drug.
BRUSSELS, July 25 (Reuters) - European Union ambassadors asked the European Commission on Friday to draw up a legal text to impose sectoral sanctions on Russia, but there is no final agreement yet to impose them, EU diplomats said.
BRUSSELS (Reuters) - European Union antitrust regulators will decide by Aug. 29 whether to clear world No. 2 software maker Oracle Corp's $5.3 billion bid for Micros Systems , the European Commission said on Friday.